Investing in drug safety monitoring systems can help improve patient safety as well as reduce healthcare costs, according to study published in Medical Care. Researchers examined three cases in which ...

In the U.S., all new pharmaceuticals undergo rigorous safety testing and approvals before being sold to the public. Despite these measures, some adverse drug reactions (ADRs) are not detected until ...

Ensuring the safety of medications doesn't end once they’re approved - it’s an ongoing process that requires careful, continuous monitoring. While clinical trials provide critical data on efficacy and ...

Nearly 70% of cancer drugs granted FDA accelerated approval between 2011 and 2020 required safety updates within 4 years.“Postmarketing safety actions are common,” Maryam Mooghali, MD, MSc, internal ...

In 2019-2022, Joel Lexchin received payments for writing briefs on the role of promotion in generating prescriptions for two legal firms. He is a member of the Foundation Board of Health Action ...

Imagine taking a prescription drug for months — only to learn it increases your risk of stroke or heart failure. When a new drug receives regulatory approval, doctors and patients assume it is safe.

Pharmaceutical-sector focussed AI startup Graph AI’s $3 Mn seed funding round was led by Bessemer Venture Partners The startup will use the capital for product innovation, team expansion, and ...

An inter-departmental research team has conducted an analytic real-world cohort study on the association of clozapine, a highly efficacious antipsychotic drug, with the incidence of blood cancer.

As drug contaminants are rapidly evolving, the state may need to ramp up monitoring and oversight of its drug supply.